GO:0110154 RNA decapping: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0110154 RNA decapping is the biological process defined as the cleavage of the 5'-cap of an RNA, a committed step in RNA turnover and quality control.
• Decapping removes the protective 5' cap, exposing the RNA body to 5'-to-3' exonucleases and committing the transcript to degradation.
• Decapping occurs both inside and outside of processing bodies (P-bodies), indicating compartmentalized regulation of mRNA stability.
• Beyond canonical m7G caps, noncanonical decapping pathways act on NAD-RNA and other modified caps, expanding the chemical diversity of decapping substrates.
• Decapping can be largely independent of initial deadenylation, showing that cap removal is not always a strictly sequential downstream event.
• Decapping enzymes such as RppH and Dcp2 are studied with gel-based, aptamer-based, and light-up NAD-RNA assays that enable substrate profiling and high-throughput screening.
Description
RNA decapping (GO:0110154) is the enzymatic cleavage of the 5'-cap of an RNA molecule, a reaction that removes the protective cap structure and exposes the transcript to exonucleolytic degradation. Because the 5' cap is essential for mRNA stability, translation initiation, and nuclear export, its removal is a decisive regulatory event in gene expression. The process is conserved across eukaryotes, bacteria, and archaea, and it operates on both canonical m7G-capped RNAs and noncanonical capped species such as NAD-RNAs. Researchers study RNA decapping to understand how cells control transcript half-lives, how they eliminate aberrant or damaged RNAs, and how these pathways are rewired in disease. The reaction is also a focal point for method development, because measuring decapping activity requires sensitive assays that can distinguish cap removal from downstream degradation. As a Gene Ontology biological process, GO:0110154 provides a precise annotation target for functional genomics, CRISPR screens, and mechanistic enzymology.
RNA decapping At A Glance
| GO ID | GO:0110154 |
|---|---|
| GO term | RNA decapping |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Definition | Cleavage of the 5'-cap of an RNA |
| Major function | Removal of the 5' cap to commit RNA to degradation and regulate transcript stability |
| Substrate scope | Canonical m7G caps and noncanonical caps such as NAD-RNA and ADPR-RNA |
| Cellular context | Occurs inside and outside processing bodies |
| Related enzymes | Decapping enzymes including Dcp2 and RppH |
What Is GO:0110154?
In the Gene Ontology, GO:0110154 RNA decapping is defined as the cleavage of the 5'-cap of an RNA. In practical terms, this means an enzyme hydrolyzes the cap structure at the 5' end of a transcript, removing the modification that normally protects the RNA and recruits translation machinery. The reaction can target canonical caps such as m7G and noncanonical caps such as NAD or ADPR modifications, and it can occur in different cellular compartments including processing bodies.
Why Is RNA decapping Important in Cell Biology?
RNA decapping is important because it is a point of no return in RNA metabolism: once the 5' cap is cleaved, the transcript is vulnerable to exonucleases and can no longer be efficiently translated. This makes decapping a central control node for mRNA half-life, RNA quality control, and the cellular response to changing conditions. The discovery of noncanonical decapping pathways for NAD-RNAs and ADPR-RNAs has further broadened the biological significance of GO:0110154, linking cap chemistry to metabolic and stress signaling. Because decapping enzymes are tractable enzymatic targets, they are also important for assay development and inhibitor discovery.
• Controls mRNA stability by removing the protective 5' cap and committing transcripts to degradation.
• Acts as a quality-control step that prevents translation of aberrant or unwanted RNAs.
• Occurs in processing bodies and other compartments, linking decapping to RNA granule biology.
• Can proceed independently of initial deadenylation, revealing alternative routes to RNA decay.
• Targets noncanonical caps such as NAD-RNA, connecting RNA decay to cellular metabolism.
• Is conserved in archaea, where ADPR-RNA decapping has been identified.
• Provides a measurable enzymatic activity for high-throughput substrate profiling.
• Can be quantified with gel-based assays, supporting mechanistic and kinetic studies.
• Represents a potential vulnerability in diseases characterized by dysregulated RNA turnover.
• Serves as an annotation target for functional genomics and CRISPR screening.
What Happens During RNA decapping?
Recognition of the capped RNA substrate
In simple terms: First, the decapping enzyme must find and bind the capped end of the RNA.
Decapping begins with recognition of the 5' cap structure by a decapping enzyme. The cap is a chemical modification at the 5' terminus that normally protects the RNA and supports translation, so its recognition is a specific event. Structural and biochemical studies of enzymes such as RppH have revealed distinct RNA recognition mechanisms that govern how capped substrates are engaged. This step determines which RNAs become substrates for decapping and is therefore a key point of selectivity.
Catalytic cleavage of the 5' cap
In simple terms: The enzyme then cuts the cap off the RNA.
The defining event of GO:0110154 is the cleavage of the 5'-cap of an RNA. This hydrolysis removes the cap structure and leaves the RNA body with a 5' end that is no longer protected. The reaction can act on canonical caps as well as noncanonical caps, including NAD-RNA and ADPR-RNA, expanding the range of substrates beyond the classical m7G cap. Assays for decapping activity typically detect the release or loss of the cap, providing direct evidence of cleavage.
Commitment to RNA degradation
In simple terms: Once the cap is gone, the RNA is marked for destruction.
After cap removal, the RNA becomes susceptible to 5'-to-3' exonucleases and is committed to degradation. Decapping is therefore a decisive step in RNA turnover and quality control. Importantly, decapping can occur largely independently of initial deadenylation, indicating that cap removal is not always a strictly sequential downstream event in the decay pathway. This flexibility allows cells to degrade specific transcripts through multiple routes.
Spatial organization inside and outside processing bodies
In simple terms: Decapping happens in specific places in the cell, including P-bodies.
RNA decapping occurs both inside and outside of processing bodies, which are cytoplasmic RNA granules associated with RNA decay. This spatial organization suggests that decapping is compartmentalized and regulated in a location-dependent manner. The presence of decapping activity in distinct cellular contexts allows the cell to coordinate RNA stability with other processes such as storage and translational repression.
Noncanonical decapping pathways
In simple terms: Some RNAs carry unusual caps, and dedicated enzymes remove them.
Beyond canonical m7G caps, noncanonical capping and decapping pathways have been described for NAD-RNA and related species. A novel NAD-RNA decapping pathway was discovered using synthetic light-up NAD-RNAs, demonstrating that NAD caps can be enzymatically removed. In archaea, NAD-RNA species and ADPR-RNA decapping have been identified, showing that noncanonical decapping is evolutionarily widespread. These findings expand the biochemical scope of GO:0110154 beyond the classical cap.
Key Genes Involved in GO:0110154 RNA decapping
The following genes and proteins are experimentally implicated in RNA decapping or in the assays and pathways used to study it.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DCP2 | Catalytic subunit of the decapping complex that removes the 5' cap | Core enzyme for canonical mRNA decapping studies |
| DCP1 | Regulatory partner of DCP2 in the decapping complex | Required for efficient decapping activity and complex assembly |
| RPPH | Bacterial decapping enzyme that removes pyrophosphate from triphosphorylated RNA ends | Model enzyme for RNA recognition and Np4 decapping studies |
| NUDT16 | Decapping enzyme acting on capped RNA | Studied for noncanonical decapping and substrate specificity |
| DCPS | Scavenger decapping enzyme that hydrolyzes cap structures | Target for understanding cap catabolism |
| NUDT12 | NAD-RNA decapping enzyme | Key enzyme for NAD-RNA decapping pathway research |
| NUDT13 | NAD-RNA decapping enzyme | Studied in NAD-RNA turnover and mitochondrial RNA biology |
| DXO | Decapping and exoribonuclease enzyme | Links decapping to quality control of incompletely capped RNAs |
| XRN1 | 5'-to-3' exoribonuclease acting after decapping | Downstream effector of decapping in RNA decay |
| LSM1 | Component of the Lsm1-7 complex that promotes decapping | Regulates decapping activation on deadenylated mRNAs |
| PAT1 | Decapping activator that interacts with Lsm1-7 | Studied for decapping stimulation and P-body localization |
| EDC3 | Enhancer of decapping | Modulates decapping efficiency and P-body formation |
| EDC4 | Scaffold protein in the decapping complex | Required for decapping complex integrity |
| DDX6 | RNA helicase associated with decapping | Regulates decapping and translational repression |
| RAP55 | Decapping-associated protein | Studied in mRNA decay and P-body biology |
| ADPRH | ADPR-RNA decapping activity in archaea | Model for noncanonical decapping in archaea |
How Is RNA decapping Regulated?
RNA decapping is regulated at multiple levels. The activity of the decapping complex is controlled by accessory proteins such as Lsm1-7, Pat1, Edc3, and Edc4, which stimulate or scaffold the reaction. Decapping is also spatially regulated, occurring both inside and outside processing bodies, which allows the cell to couple RNA decay to granule dynamics. In addition, decapping can be uncoupled from deadenylation, indicating that upstream decay steps do not always dictate when cap removal occurs. Noncanonical decapping pathways add another layer of regulation by targeting NAD-RNA and ADPR-RNA species whose levels reflect metabolic and stress states.
RNA decapping and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DCP2 | Cancer and RNA turnover dysregulation | DCP2 knockout cell line with RNA-seq |
| NUDT12 | Metabolic stress and NAD-RNA metabolism | NUDT12 overexpression and NAD-RNA profiling |
| NUDT13 | Mitochondrial RNA biology and metabolic disease | NUDT13 point-mutation knock-in |
| DXO | RNA quality control and autoimmunity | DXO knockout with capped RNA reporters |
| XRN1 | RNA decay and viral replication | XRN1 knockout with transcript stability assays |
RNA decapping and cancer
Dysregulated RNA turnover can alter the stability of transcripts that control cell growth and survival. Because decapping commits RNAs to degradation, changes in decapping activity can shift the abundance of oncogenic or tumor-suppressive transcripts. Experimental models that manipulate decapping enzymes are therefore useful for testing whether altered RNA stability contributes to cancer phenotypes.
RNA decapping and neurological disease
Neurons are particularly sensitive to defects in RNA metabolism, and processing bodies are implicated in RNA granule biology in neuronal cells. Decapping enzymes and their regulators are studied in the context of RNA quality control, which is critical for neuronal function. Noncanonical decapping of NAD-RNAs may also link metabolic stress to RNA stability in the nervous system.
RNA decapping and metabolic stress
NAD-RNA decapping connects RNA stability to cellular metabolism, because NAD is a central metabolic cofactor. Enzymes such as NUDT12 and NUDT13 remove NAD caps, and their activity can influence how cells respond to metabolic stress. In archaea, ADPR-RNA decapping has been identified, highlighting the evolutionary conservation of these noncanonical pathways.
From RNA decapping-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a decapping enzyme required for mRNA turnover? | Knockout cell line plus RNA-seq |
| Does a catalytic residue control decapping activity? | Point-mutation knock-in of the catalytic site |
| Where does decapping occur in the cell? | Tagged knock-in with imaging |
| Does overexpression of a decapping enzyme alter transcript stability? | Overexpression cell model with RNA stability assays |
| Which substrates are cleaved by a decapping enzyme? | Aptamer-based substrate profiling |
| Can decapping be measured quantitatively? | Gel electrophoresis-based decapping assay |
How to Study the RNA decapping Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Gel electrophoresis-based decapping assay | Cleavage of capped RNA substrates | Kinetic analysis of decapping enzymes |
| Aptamer-based assay | Substrate specificity of decapping enzymes | High-throughput substrate profiling |
| Light-up NAD-RNA assay | NAD-RNA decapping activity | Discovery of noncanonical decapping pathways |
| RNA-seq | Global transcript abundance and stability | Knockout and overexpression studies |
| Transcript stability time-course | Decay rates of individual transcripts | Testing deadenylation-independent decapping |
| Structural biology | RNA recognition and catalytic mechanism | Mechanistic studies of RppH and Dcp2 |
| Archaeal NAD-RNA profiling | NAD-RNA and ADPR-RNA species | Comparative decapping studies |
| Fluorescence imaging | Localization of decapping factors | Processing body dynamics |
Gel electrophoresis-based decapping assays
Gel electrophoresis-based assays allow direct measurement of enzymatic RNA decapping activity by resolving capped and decapped RNA species. These methods are useful for kinetic analysis and for comparing wild-type and mutant decapping enzymes.
Aptamer-based substrate profiling
Aptamer-based assays enable high-throughput substrate profiling of RNA decapping enzymes, allowing researchers to test many RNA substrates in parallel. This approach is valuable for defining substrate specificity and for screening enzyme variants.
Light-up NAD-RNA assays
Synthetic light-up NAD-RNAs provide a sensitive readout for NAD-RNA decapping, and this strategy was used to discover a novel NAD-RNA decapping pathway. Such assays are particularly useful for noncanonical decapping enzymes that act on NAD caps.
RNA-seq and transcript stability profiling
RNA-seq and transcript stability measurements can reveal the consequences of altering decapping activity on global RNA turnover. Because decapping can be independent of deadenylation, careful time-course experiments are needed to distinguish direct effects from downstream decay.
How CRISPR Can Be Used to Study GO:0110154 RNA decapping
Knockout
CRISPR knockout of decapping enzyme genes such as DCP2 or XRN1 can be used to test whether decapping is required for normal RNA turnover and cell viability. Knockout models combined with RNA-seq reveal the set of transcripts whose stability depends on the enzyme.
Point Mutation
Point-mutation knock-in of catalytic residues in decapping enzymes allows separation of enzymatic activity from scaffolding functions. Such models are essential for determining whether a specific residue is required for cap cleavage.
Knock-in
Tagged knock-in of decapping factors enables visualization of their localization inside and outside processing bodies. Knock-in reporters can also be used to monitor decapping of specific transcripts in live cells.
Overexpression
Overexpression of decapping enzymes such as NUDT12 can be used to test whether increased decapping activity alters NAD-RNA levels and transcript stability. Overexpression models are also useful for producing enzyme for biochemical assays.
How EDITGENE Supports RNA decapping Research
Researchers studying RNA decapping-related genes often need to determine whether a candidate gene is causally involved in cap removal, RNA stability, or downstream decay. EDITGENE provides CRISPR-based cell models and screening services that allow precise interrogation of GO:0110154-related genes in relevant cellular contexts.
Contact EDITGENE today to design your custom CRISPR model for RNA decapping research.
Frequently Asked Questions About RNA decapping
What is RNA decapping?
RNA decapping is the cleavage of the 5'-cap of an RNA, a biological process annotated as GO:0110154 that commits the transcript to degradation.
What genes are involved in RNA decapping?
Genes involved include DCP2, DCP1, RPPH, NUDT12, NUDT13, DXO, XRN1, LSM1, PAT1, EDC3, EDC4, and DDX6, among others.
Where does RNA decapping occur in the cell?
RNA decapping occurs both inside and outside of processing bodies.
Is decapping dependent on deadenylation?
Decapping can be largely independent of initial deadenylation, indicating that cap removal is not always a strictly sequential downstream event.
What are noncanonical decapping pathways?
Noncanonical decapping pathways act on modified caps such as NAD-RNA and ADPR-RNA, in addition to canonical m7G caps.
How is RNA decapping measured?
Decapping can be measured with gel electrophoresis-based assays, aptamer-based substrate profiling, and light-up NAD-RNA assays.
Which enzyme removes NAD caps from RNA?
NUDT12 and NUDT13 are NAD-RNA decapping enzymes, and a novel NAD-RNA decapping pathway has been discovered using synthetic light-up NAD-RNAs.
Is RNA decapping conserved in archaea?
Yes, NAD-RNA species and ADPR-RNA decapping have been identified in archaea.
What is the role of RppH in decapping?
RppH is a bacterial decapping enzyme, and a distinct RNA recognition mechanism governs Np4 decapping by RppH.
Why is RNA decapping important for disease research?
Decapping controls transcript stability and RNA quality control, processes that are linked to cancer, neurological disease, and metabolic stress.
Conclusion
GO:0110154 RNA decapping is a fundamental biological process that removes the 5' cap from RNA and commits transcripts to degradation. It operates on canonical and noncanonical caps, occurs in multiple cellular compartments, and can proceed independently of deadenylation. Understanding decapping requires a combination of enzymatic assays, structural studies, and functional genomics, and CRISPR-based models provide a powerful way to test causality. As new noncanonical decapping pathways are discovered, the importance of this process for RNA biology and disease continues to grow.
References
- 1. Doamekpor SK et al.. 2022. Recent insights into noncanonical 5' capping and decapping of RNA.. J Biol Chem 298(8):102171 PMID: 35750211
- 2. Fillman C et al.. 2005. RNA decapping inside and outside of processing bodies.. Curr Opin Cell Biol 17(3):326-31 PMID: 15901504
- 3. Abele F et al.. 2020. A Novel NAD-RNA Decapping Pathway Discovered by Synthetic Light-Up NAD-RNAs.. Biomolecules 10(4) PMID: 32231086
- 4. Audebert L et al.. 2024. RNA degradation triggered by decapping is largely independent of initial deadenylation.. EMBO J 43(24):6496-6524 PMID: 39322754
- 5. Levenson-Palmer R et al.. 2022. A distinct RNA recognition mechanism governs Np(4) decapping by RppH.. Proc Natl Acad Sci U S A 119(6) PMID: 35131855
- 6. Gomes-Filho JV et al.. 2023. Identification of NAD-RNA species and ADPR-RNA decapping in Archaea.. Nat Commun 14(1):7597 PMID: 37989750
- 7. Grab K et al.. 2024. Aptamer-based assay for high-throughput substrate profiling of RNA decapping enzymes.. Nucleic Acids Res 52(21):e100 PMID: 39445825
- 8. Singh Y et al.. 2022. A gel electrophoresis-based assay for measuring enzymatic RNA decapping activity.. Methods Enzymol 675:323-350 PMID: 36220275
